| Schedule of Cash and Cash Equivalents |
Cash
and cash equivalents consists of the following:
Schedule of Cash and Cash Equivalents
| |
|
June 30,
2020 |
|
|
December 31,
2019 |
|
| Cash |
|
$ |
764,791 |
|
|
$ |
884,115 |
|
| Money market fund |
|
|
62,703,978 |
|
|
|
30,864,571 |
|
| Total cash and cash equivalents |
|
$ |
63,468,769 |
|
|
$ |
31,748,686 |
|
|
| Schedule of Computation of Net Income (Loss) Per Share |
Net
income (loss) per share was computed as follows:
Schedule of Computation of Net Income (Loss) Per Share
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three
Months Ended June
30
|
|
|
Six
Months Ended June
30
|
|
| |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
$ |
(38,105,323 |
) |
|
$ |
2,152,653 |
|
|
$ |
(67,762,123 |
) |
|
$ |
(24,082,156 |
) |
| Weighted average number of common shares-basic |
|
|
73,885,548 |
|
|
|
64,546,628 |
|
|
|
71,578,975 |
|
|
|
63,119,196 |
|
| Effect of dilutive securities |
|
|
— |
|
|
|
3,964,959 |
|
|
|
— |
|
|
|
— |
|
| Weighted average number of common shares-diluted |
|
|
73,885,548 |
|
|
|
68,511,587 |
|
|
|
71,578,975 |
|
|
|
63,119,196 |
|
| Net income (loss) per share of common stock-basic |
|
$ |
(0.52 |
) |
|
$ |
0.03 |
|
|
$ |
(0.95 |
) |
|
$ |
(0.38 |
) |
| Net income (loss) per share of common stock-diluted |
|
$ |
(0.52 |
) |
|
$ |
0.03 |
|
|
$ |
(0.95 |
) |
|
$ |
(0.38 |
) |
| Antidilutive awards (1) |
|
|
— |
|
|
|
281,132 |
|
|
|
— |
|
|
|
317,945 |
|
| (1) |
Certain
stock-based compensation awards were not included in the calculation of net income per common share for the three months ended
June 30, 2019 because their effect would have been antidilutive. For the three months ended June 30, 2020 and the six months
ended June 30, 2020 and 2019, the effect of dilutive shares was not included in the computation of net loss per share because
the Company had a net loss. |
|